Author

Haijun Yu

Chinese Academy of SciencesORCID 0000-0002-3398-0880Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:benchmark study· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Assay:GWAS summary statistics· 1

Frequent Co-Authors

Bo Dong· 1 shared Bo ZhangiD· 1 shared Chubin OuiD· 1 shared Dingyan WangiD· 1 shared Duo AniD· 1 shared Fangzhou Lin· 1 shared Feng Tang· 1 shared HaoMing Xue· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Bo Dong

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

OriGene: A Self-Evolving Virtual Disease Biologist Automating Therapeutic Target Discovery

Zhongyue Zhang, Zijie Qiu, Yingcheng Wu, Sitan Li, Dingyan Wang, Yong Liu, Zhuomin Zhou, Yusong Hu, Yuhan Chen, Duo An, Yongbo Wang, Haijun Yu, Zhenyi Zhong, Chubin Ou, Zichen Wang, , Shuangjia Zheng

OriGene identifies therapeutic targets by integrating diverse data modalities and outperforms human experts and models in accuracy and robustness.

bioRxiv · Jun 3, 2025 · PreprintBioinformatics

Engineering PEG10 assembled endogenous virus-like particles with genetically encoded neoantigen peptides for cancer vaccination

Ruijing Tang, Luobin Guo, Tingyu Wei, Tingting Chen, Huan Yang, Honghao Ye, Fangzhou Lin, Yongyi Zeng, Haijun Yu, Zhixiong Cai, Xiaolong Liu

This paper develops ePAC, a cancer vaccine using PEG10-based virus-like particles to deliver neoantigens and adjuvants, showing efficacy in preclinical models.

eLife · Jun 20, 2024Peer-reviewedCancer Biology